Zhen Huang

Direttore/Membro del Consiglio presso WALVAX BIOTECHNOLOGY CO., LTD.

Patrimonio netto: 57 M $ in data 31/05/2024

61 anni

Health Technology

Profilo

Zhen Huang currently works at Walvax Biotechnology Co., Ltd., as Vice Chairman from 2019, Shanghai Zerun Biotechnology Co., Ltd., as Director, and Yuxi Walvax Biotechnology Co., Ltd., as President.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
WALVAX BIOTECHNOLOGY CO., LTD. CLASS A 1.14%	30/06/2023	17 698 729 ( 1.14% )	33 M $	31/05/2024
WALVAX BIOTECHNOLOGY CO., LTD. 28.09%	30/09/2023	13 274 047 ( 28.09% )	24 M $	31/05/2024

Posizioni attive di Zhen Huang

Società	Posizione	Inizio
WALVAX BIOTECHNOLOGY CO., LTD.	Direttore/Membro del Consiglio	22/08/2019
Yuxi Walvax Biotechnology Co., Ltd.	Presidente	-
Shanghai Zerun Biotechnology Co., Ltd. Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Zhen Huang

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zhen Huang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
WALVAX BIOTECHNOLOGY CO., LTD.	Health Technology

Aziende private	2
Yuxi Walvax Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.	Health Technology